1. |
Jabr-M ilane LS, van Vlerken LE, Yadav S. Multi-functional nanocarriers to overcome tumor drugresistance[J]. Cancer Treat Rev, 2008, 34(7): 592-595.
|
2. |
Meijerman I, Beijnen JH, Schellens JH. Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer[J]. Cancer Treat Rev, 2008, 34(6): 505-509.
|
3. |
Seeger M, Veen H. Molecular basis of multidrug transport by ABC transporters[J]. Biochim Biophys Acta, 2009, 1794(5): 725-728.
|
4. |
徐珊, 徐昌芬. 腫瘤多藥耐藥性發生機制及中藥逆轉作用的研究進展[J]. 中國腫瘤生物治療雜志, 2006, 13(6): 404-411.
|
5. |
王家騏, 梅炯, 蔡宣松. 骨肉瘤化療的現狀和研究進展[J] . 同濟大學學報, 2004, 25(6): 538-540.
|
6. |
Link MP, Gebhardt MC, M eyers PA, et al. In Principles and Practice of Pediatric Oncology[M]. 4th ed. Philadelph ia: Lippincott Williams & Wilkins, 2002: 1051-1089.
|
7. |
張文韜, 劉洋. 人成骨肉瘤順鉑耐藥細胞系的建立[J]. 四川大學學報, 2006, 37(2): 262-165.
|
8. |
王進, 沈靖南. 粉防己堿逆轉骨肉瘤細胞系多藥耐藥性的研究[J]. 實用臨床醫學, 2005, 6(7): 7-10.
|